Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jazzmyne Montgomery

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Urology|January 23, 2026
Editorial Comment on "Fear of Cancer Recurrence among Uninsured and Underrepresented Men with Prostate Cancer"Jazzmyne Montgomery
Urology Practice|May 5, 2023
Editorial CommentaryJazzmyne Montgomery, Brad Schwartz
Current Opinion in Urology|May 16, 2026
The role of structural racism in shaping urologic outcomesJazzmyne Montgomery, Kelvin Moses
Urology Practice|May 5, 2023
Editorial CommentaryRanjiv Mathews, Jazzmyne Montgomery
Journal of the National Cancer Institute|June 2, 2026
Private equity acquisitions and cancer care: nothing to see here? Not so fastJazzmyne Montgomery, Vahakn B Shahinian
Urology|December 3, 2019
"Sterile" Epididymal Abscess With Contralateral Intratesticular RecurrenceChirag P Doshi, Jazzmyne Montgomery, Marcus L Quek, et al.
Clinical Genitourinary Cancer|March 30, 2024
Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guérin TreatmentJazzmyne Montgomery, Daniel Lybbert, Sherjeel Sana, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Urology|January 23, 2026
Editorial Comment on "Fear of Cancer Recurrence among Uninsured and Underrepresented Men with Prostate Cancer"Jazzmyne Montgomery
Urology Practice|May 5, 2023
Editorial CommentaryJazzmyne Montgomery, Brad Schwartz
Current Opinion in Urology|May 16, 2026
The role of structural racism in shaping urologic outcomesJazzmyne Montgomery, Kelvin Moses
Urology Practice|May 5, 2023
Editorial CommentaryRanjiv Mathews, Jazzmyne Montgomery
Journal of the National Cancer Institute|June 2, 2026
Private equity acquisitions and cancer care: nothing to see here? Not so fastJazzmyne Montgomery, Vahakn B Shahinian
Urology|December 3, 2019
"Sterile" Epididymal Abscess With Contralateral Intratesticular RecurrenceChirag P Doshi, Jazzmyne Montgomery, Marcus L Quek, et al.
Clinical Genitourinary Cancer|March 30, 2024
Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guérin TreatmentJazzmyne Montgomery, Daniel Lybbert, Sherjeel Sana, et al.
Pageof 1